Tango Therapeutics (TNGX) Net Income towards Common Stockholders Growth (1y) (2021 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | -58.11% |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | -95.76% |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | -290.15% |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 59.59% |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | -129.68% |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | -10.08% |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 1,228.66% |
| 10 | Tango Therapeutics | 3.16 Bn | 2.78 Bn | - | -14.14% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -14.14% |
| Dec 31, 2025 | -2.89% |
| Sep 30, 2025 | 154.46% |
| Jun 30, 2025 | -52.06% |
| Mar 31, 2025 | -5.17% |
| Dec 31, 2024 | -22.29% |
| Sep 30, 2024 | -31.01% |
| Jun 30, 2024 | -23.38% |
| Mar 31, 2024 | -35.37% |
| Dec 31, 2023 | -5.86% |
| Sep 30, 2023 | 23.36% |
| Jun 30, 2023 | 16.69% |
| Mar 31, 2023 | -11.11% |
| Dec 31, 2022 | -31.82% |
| Sep 30, 2022 | -48.29% |
| Jun 30, 2022 | -3,151.11% |
| Mar 31, 2022 | -108.23% |
| Dec 31, 2021 | -17,816.88% |
| Sep 30, 2021 | 26.91% |
| Jun 30, 2021 | -161,891.74% |